Revolution Medicines, Inc.
RVMD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001628171
In the last 90 days, Revolution Medicines, Inc. insiders filed 0 open-market purchases and 16 sales; 693 institutions reported holding it in 13F filings for Q2 2026, worth $40.1B in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesRVMDW
13F holders, Q1 2024
Institutional positions in Revolution Medicines, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 210
- +26 vs. Q4 2023
- Shares held
- 160.6M
- +615.9K (+0.4%) vs. Q4 2023
- Total value
- $5.18B
- +$587.1M (+12.8%) vs. Q4 2023
- New holders
- 50
- 56 more added
- Sold out
- 24
- 65 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 693 | $40.1B |
| Q1 2026 | 514 | $19.1B |
| Q4 2025 | 387 | $15.9B |
| Q3 2025 | 323 | $8.96B |
| Q2 2025 | 308 | $7.02B |
| Q1 2025 | 284 | $6.83B |
| Q4 2024 | 281 | $8.45B |
| Q3 2024 | 255 | $7.74B |
| Q2 2024 | 223 | $6.54B |
| Q1 2024 | 210 | $5.18B |
| Q4 2023 | 184 | $4.59B |
| Q3 2023 | 168 | $3.11B |
| Q2 2023 | 139 | $2.99B |
| Q1 2023 | 152 | $2.34B |
| Q4 2022 | 135 | $2.10B |
| Q3 2022 | 142 | $1.74B |
| Q2 2022 | 135 | $1.49B |
| Q1 2022 | 126 | $1.89B |
| Q4 2021 | 117 | $1.85B |
| Q3 2021 | 114 | $1.99B |
| Q2 2021 | 130 | $2.23B |
| Q1 2021 | 128 | $3.05B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Revolution Medicines, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 14,757,112 | $475.6M | 0.01% | +122,721+0.8% | Added |
| Wellington Management Group LLP | 14,714,726 | $474.3M | 0.08% | −167,360−1.1% | Reduced |
| BlackRock Inc. | 12,308,002 | $396.7M | 0.01% | −646,312−5.0% | Reduced |
| Baker Bros. Advisors LP | 7,549,249 | $243.3M | 3.05% | +2,400,592+46.6% | Added |
| Farallon Capital Management, L.L.C. | 7,507,872 | $242.0M | 1.42% | +771,018+11.4% | Added |
| Nextech Invest AG | 6,296,740 | $202.9M | 32.17% | 00.0% | Unchanged |
| BVF Inc | 5,981,212 | $192.8M | 5.30% | 00.0% | Unchanged |
| Casdin Capital, LLC | 5,617,599 | $181.1M | 13.47% | −97,176−1.7% | Reduced |
| State Street Corp | 5,386,020 | $173.6M | 0.01% | −867,341−13.9% | Reduced |
| Alphabet Inc. | 5,301,512 | $170.9M | 6.80% | 00.0% | Unchanged |
| Bellevue Group AG | 5,073,600 | $163.5M | 2.49% | −17,400−0.3% | Reduced |
| Price T Rowe Associates Inc | 4,814,310 | $155.2M | 0.02% | +177,957+3.8% | Added |
| Boxer Capital, LLC | 4,279,464 | $137.9M | 6.81% | 00.0% | Unchanged |
| FMR LLC | 4,166,765 | $134.3M | 0.01% | +2,615+0.1% | Added |
| Janus Henderson Group PLC | 3,912,119 | $126.1M | 0.07% | +1,712,639+77.9% | Added |
| Woodline Partners LP | 3,797,148 | $122.4M | 1.13% | +837,108+28.3% | Added |
| JPMorgan Chase & Co | 3,509,104 | $113.1M | 0.01% | −882,525−20.1% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 3,090,073 | $99.6M | 1.73% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 3,052,691 | $98.4M | 0.01% | +73,907+2.5% | Added |
| Paradigm Biocapital Advisors LP | 2,914,975 | $93.9M | 3.31% | +2,914,975 | New |
| AH Capital Management, L.L.C. | 2,748,523 | $88.6M | 6.41% | −2,948,544−51.8% | Reduced |
| Holocene Advisors, LP | 2,422,411 | $78.1M | 0.29% | −459,744−16.0% | Reduced |
| Norges Bank | 1,708,276 | $55.1M | 0.01% | +1,426,571+506.4% | Added |
| Ameriprise Financial Inc | 1,694,501 | $54.6M | 0.02% | +71,480+4.4% | Added |
| Balyasny Asset Management LLC | 1,654,895 | $53.3M | 0.14% | +1,087,790+191.8% | Added |
| Marshall Wace, LLP | 1,535,940 | $49.5M | 0.08% | +327,011+27.0% | Added |
| Dimensional Fund Advisors LP | 1,331,259 | $42.9M | 0.01% | −464,162−25.9% | Reduced |
| Artal Group S.A. | 1,318,649 | $42.5M | 1.10% | −377,300−22.2% | Reduced |
| Northern Trust Corp | 1,214,271 | $39.1M | 0.01% | −56,524−4.4% | Reduced |
| Goldman Sachs Group Inc | 1,123,450 | $36.2M | 0.01% | +70,193+6.7% | Added |
| Charles Schwab Investment Management Inc | 1,052,263 | $33.9M | 0.01% | +9,296+0.9% | Added |
| Frazier Life Sciences Management, L.P. | 997,455 | $32.1M | 1.36% | 00.0% | Unchanged |
| Morgan Stanley | 927,070 | $29.9M | 0.00% | −726,104−43.9% | Reduced |
| Rock Springs Capital Management LP | 923,681 | $29.8M | 0.76% | +198,529+27.4% | Added |
| Soleus Capital Management, L.P. | 728,700 | $23.5M | 2.06% | +476,700+189.2% | Added |
| Finepoint Capital LP | 677,100 | $21.8M | 5.60% | +60,000+9.7% | Added |
| Avidity Partners Management LP | 635,000 | $20.5M | 0.73% | +575,000+958.3% | Added |
| Perceptive Advisors LLC | 618,885 | $19.9M | 0.35% | −199,997−24.4% | Reduced |
| Victory Capital Management Inc | 600,581 | $19.4M | 0.02% | +42,212+7.6% | Added |
| Citadel Advisors LLC | 588,088 | $19.0M | 0.02% | −315,941−34.9% | Reduced |
| Candriam Luxembourg S.C.A. | 583,950 | $18.8M | 0.12% | −23,000−3.8% | Reduced |
| Bank of America Corp | 544,086 | $17.5M | 0.00% | +298,079+121.2% | Added |
| Bank of New York Mellon Corp | 529,409 | $17.1M | 0.00% | −51,807−8.9% | Reduced |
| DAFNA Capital Management LLC | 511,894 | $16.5M | 3.76% | 00.0% | Unchanged |
| MIC Capital Management UK LLP | 508,569 | $16.4M | 3.11% | 00.0% | Unchanged |
| Integral Health Asset Management, LLC | 420,000 | $13.5M | 1.33% | +220,000+110.0% | Added |
| Nuveen Asset Management, LLC | 373,775 | $12.0M | 0.00% | −10,893−2.8% | Reduced |
| Eventide Asset Management, LLC | 361,000 | $11.6M | 0.18% | 00.0% | Unchanged |
| Mass General Brigham, Inc | 338,191 | $10.9M | 19.08% | +338,191 | New |
| Alliancebernstein L.P. | 323,364 | $10.4M | 0.00% | +3,119+1.0% | Added |
| UBS Group AG | 304,979 | $9.83M | 0.00% | −1,579−0.5% | Reduced |
| Voya Investment Management LLC | 291,465 | $9.39M | 0.01% | +108,284+59.1% | Added |
| Great Lakes Advisors, LLC | 288,820 | $9.31M | 0.08% | +288,820 | New |
| Rafferty Asset Management, LLC | 284,352 | $9.16M | 0.03% | −80,743−22.1% | Reduced |
| Mubadala Investment Co PJSC | 278,000 | $8.96M | 0.04% | 00.0% | Unchanged |
| Citigroup Inc | 277,675 | $8.95M | 0.01% | +116,634+72.4% | Added |
| MPM Oncology Impact Management LP | 273,217 | $8.81M | 1.42% | −191−0.1% | Reduced |
| TD Asset Management Inc | 254,594 | $8.21M | 0.01% | −17,166−6.3% | Reduced |
| Bessemer Group Inc | 243,442 | $7.85M | 0.01% | 00.0% | Unchanged |
| Rhumbline Advisers | 209,310 | $6.75M | 0.01% | +3,952+1.9% | Added |
| Susquehanna Fundamental Investments, LLC | 206,513 | $6.66M | 0.31% | +206,513 | New |
| Swiss National Bank | 200,131 | $6.45M | 0.00% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 200,000 | $6.45M | 0.01% | +200,000 | New |
| Manufacturers Life Insurance Company, The | 199,050 | $6.42M | 0.01% | +20,063+11.2% | Added |
| Qube Research & Technologies Ltd | 167,480 | $5.40M | 0.01% | +141,965+556.4% | Added |
| HSBC Holdings PLC | 167,149 | $5.38M | 0.00% | +167,149 | New |
| Acuta Capital Partners, LLC | 143,777 | $4.63M | 3.01% | −16,223−10.1% | Reduced |
| Neuberger Berman Group LLC | 143,359 | $4.62M | 0.00% | +57,577+67.1% | Added |
| Barclays PLC | 135,416 | $4.36M | 0.00% | −218,369−61.7% | Reduced |
| UBS Asset Management Americas Inc | 133,174 | $4.29M | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 129,467 | $4.17M | 0.01% | −66,765−34.0% | Reduced |
| Alps Advisors Inc | 116,156 | $3.74M | 0.03% | +4,952+4.5% | Added |
| Credit Suisse AG | 112,301 | $3.62M | 0.00% | +16,543+17.3% | Added |
| Legal & General Group Plc | 106,129 | $3.42M | 0.00% | −2,553−2.3% | Reduced |
| California State Teachers Retirement System | 105,373 | $3.40M | 0.00% | −8,732−7.7% | Reduced |
| Deutsche Bank AG | 96,861 | $3.12M | 0.00% | −20,974−17.8% | Reduced |
| Invesco Ltd. | 94,431 | $3.04M | 0.00% | −34,387−26.7% | Reduced |
| State of New Jersey Common Pension Fund D | 91,775 | $2.96M | 0.01% | −21,615−19.1% | Reduced |
| State of Wisconsin Investment Board | 74,112 | $2.39M | 0.01% | −9,471−11.3% | Reduced |
| D. E. Shaw & Co., Inc. | 73,657 | $2.37M | 0.00% | +22,584+44.2% | Added |
| Susquehanna International Group, LLP | 72,637 | $2.34M | 0.00% | −76,015−51.1% | Reduced |
| MetLife Investment Management | 71,207 | $2.30M | 0.02% | −4,190−5.6% | Reduced |
| Voloridge Investment Management, LLC | 70,833 | $2.28M | 0.01% | +70,833 | New |
| American International Group, Inc. | 68,744 | $2.22M | 0.01% | −2,750−3.8% | Reduced |
| Seven Eight Capital, LP | 68,494 | $2.21M | 0.23% | +68,494 | New |
| Readystate Asset Management LP | 67,300 | $2.17M | 0.08% | +67,300 | New |
| HRT Financial LP | 64,053 | $2.06M | 0.01% | +64,053 | New |
| New York State Common Retirement Fund | 60,387 | $1.95M | 0.00% | −455−0.7% | Reduced |
| Moore Capital Management, LP | 55,600 | $1.79M | 0.04% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 51,991 | $1.68M | 0.00% | −13,800−21.0% | Reduced |
| Wedmont Private Capital | 49,600 | $1.64M | 0.12% | 00.0% | Unchanged |
| DekaBank Deutsche Girozentrale | 50,000 | $1.58M | 0.00% | 00.0% | Unchanged |
| Guggenheim Capital LLC | 48,590 | $1.57M | 0.01% | −3,057−5.9% | Reduced |
| Profund Advisors LLC | 46,114 | $1.49M | 0.06% | −14,993−24.5% | Reduced |
| Connor, Clark & Lunn Investment Management Ltd. | 44,938 | $1.45M | 0.01% | +44,938 | New |
| Wells Fargo & Company | 43,802 | $1.41M | 0.00% | +3,836+9.6% | Added |
| Handelsbanken Fonder AB | 40,175 | $1.29M | 0.01% | 00.0% | Unchanged |
| Ensign Peak Advisors, Inc | 39,783 | $1.28M | 0.00% | −2,007−4.8% | Reduced |
| Cinctive Capital Management LP | 38,161 | $1.23M | 0.06% | −26,947−41.4% | Reduced |
| Mirae Asset Global Investments Co., Ltd. | 51,059 | $1.21M | 0.00% | −29,346−36.5% | Reduced |